89,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Broschiertes Buch

AI, Quantum-computer designed GlybatomaqTM small molecules: GlybatomaqTM312317b: Ab initio Systematic Parameterization ofPolarizable Force Field Quantum Chemistry mechanics-based freeenergy perturbation methodologies for calculating relative solvation free energiesof a Novel Series of Supramolecular NanoLigands (NoSuNoLin) targeted to the ETS1, CASP8AP2 and FAS, LGI1, EPTP-ADAM22 Tudor domain of human PHF20-mediated Glioma and Glioblastoma cell apoptosis.

Produktbeschreibung
AI, Quantum-computer designed GlybatomaqTM small molecules: GlybatomaqTM312317b: Ab initio Systematic Parameterization ofPolarizable Force Field Quantum Chemistry mechanics-based freeenergy perturbation methodologies for calculating relative solvation free energiesof a Novel Series of Supramolecular NanoLigands (NoSuNoLin) targeted to the ETS1, CASP8AP2 and FAS, LGI1, EPTP-ADAM22 Tudor domain of human PHF20-mediated Glioma and Glioblastoma cell apoptosis.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Grigoriadis G. Ioannis has completed his PharmacistD at the age of 24 years from the Aristotle University of Thessaloniki School of Pharmacy. He has published more than 379 papers and He is the Chairman of the WAMS International Board for Pharmaceutical Biotechnology and Clinical Pharmacy and the scientific director of Biogenea Pharm.